Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Unemo

Showing results (301-310 of 438) with videos related to

Pageof 44
Sort By:
Antimicrobial Agents and Chemotherapy|January 10, 2018
Neisseria cinerea with High Ceftriaxone MIC Is a Source of Ceftriaxone and Cefixime Resistance-Mediating <i>penA</i> Sequences in Neisseria gonorrhoeaeGene Igawa, Yuka Yamagishi, Ken-Ichi Lee, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2020
Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeaeRonza Hadad, Michelle Jayne Cole, Samantha Ebeyan, et al.
Frontiers in Microbiology|April 24, 2023
Antimicrobial susceptibility surveillance and antimicrobial resistance in <i>Neisseria gonorrhoeae</i> in Africa from 2001 to 2020: A mini-reviewFrancis Kakooza, Reuben Kiggundu, Gerald Mboowa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2016
Test of Cure for Anogenital Gonorrhoea Using Modern RNA-Based and DNA-Based Nucleic Acid Amplification Tests: A Prospective Cohort StudyCarolien M Wind, Maarten F Schim van der Loeff, Magnus Unemo, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2019
High <i>in vitro</i> susceptibility to the first-in-class spiropyrimidinetrione zoliflodacin among consecutive clinical <i>Neisseria gonorrhoeae</i> isolates from Thailand (2018) and South Africa (2015-2017)Susanne Jacobsson, Ranmini Kularatne, Rossaphorn Kittiyaowamarn, et al.
BMC Infectious Diseases|February 8, 2014
Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012Beata Mlynarczyk-Bonikowska, Agnieszka Beata Serwin, Daniel Golparian, et al.
Infectious Agents and Cancer|June 11, 2016
Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancerSabina Davidsson, Paula Mölling, Jennifer R Rider, et al.
Plos One|September 2, 2020
Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensusCecilia Ferreyra, Jennifer Osborn, Francis Moussy, et al.
Plos Medicine|July 8, 2017
Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative actionTeodora Wi, Monica M Lahra, Francis Ndowa, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2013
Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failureDavid A Lewis, Charlotte Sriruttan, Etienne E Müller, et al.
Pageof 44

Showing results (301-310 of 438) with videos related to

Sort By:
Pageof 44
Antimicrobial Agents and Chemotherapy|January 10, 2018
Neisseria cinerea with High Ceftriaxone MIC Is a Source of Ceftriaxone and Cefixime Resistance-Mediating <i>penA</i> Sequences in Neisseria gonorrhoeaeGene Igawa, Yuka Yamagishi, Ken-Ichi Lee, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2020
Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeaeRonza Hadad, Michelle Jayne Cole, Samantha Ebeyan, et al.
Frontiers in Microbiology|April 24, 2023
Antimicrobial susceptibility surveillance and antimicrobial resistance in <i>Neisseria gonorrhoeae</i> in Africa from 2001 to 2020: A mini-reviewFrancis Kakooza, Reuben Kiggundu, Gerald Mboowa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2016
Test of Cure for Anogenital Gonorrhoea Using Modern RNA-Based and DNA-Based Nucleic Acid Amplification Tests: A Prospective Cohort StudyCarolien M Wind, Maarten F Schim van der Loeff, Magnus Unemo, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2019
High <i>in vitro</i> susceptibility to the first-in-class spiropyrimidinetrione zoliflodacin among consecutive clinical <i>Neisseria gonorrhoeae</i> isolates from Thailand (2018) and South Africa (2015-2017)Susanne Jacobsson, Ranmini Kularatne, Rossaphorn Kittiyaowamarn, et al.
BMC Infectious Diseases|February 8, 2014
Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012Beata Mlynarczyk-Bonikowska, Agnieszka Beata Serwin, Daniel Golparian, et al.
Infectious Agents and Cancer|June 11, 2016
Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancerSabina Davidsson, Paula Mölling, Jennifer R Rider, et al.
Plos One|September 2, 2020
Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensusCecilia Ferreyra, Jennifer Osborn, Francis Moussy, et al.
Plos Medicine|July 8, 2017
Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative actionTeodora Wi, Monica M Lahra, Francis Ndowa, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2013
Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failureDavid A Lewis, Charlotte Sriruttan, Etienne E Müller, et al.
Pageof 44